Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3491)
All Articles published online
|
Feb 15, 2000 (publication date) through Apr 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou XP, Wang HY, Yang GS, Chen ZJ, Li BA, Wu MC. Cloning and expression of MXR7 gene in human HCC tissue. World J Gastroenterol 2000; 6(1): 57-60 [PMID: 11819523 DOI: 10.3748/wjg.v6.i1.57] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v6/i1/57.htm |
| Number | Citing Articles |
| 1 |
Dina H. Kandil, Kumarasen Cooper. Glypican-3. Advances in Anatomic Pathology 2009; 16(2): 125 doi: 10.1097/PAP.0b013e3181992455
|
| 2 |
Yoshitaka Hippo, Kiyotaka Watanabe, Akira Watanabe, Yutaka Midorikawa, Shogo Yamamoto, Sigeo Ihara, Susumu Tokita, Hiroko Iwanari, Yukio Ito, Kiyotaka Nakano, Jun-ichi Nezu, Hiroyuki Tsunoda, Takeshi Yoshino, Iwao Ohizumi, Masayuki Tsuchiya, Shin Ohnishi, Masatoshi Makuuchi, Takao Hamakubo, Tatsuhiko Kodama, Hiroyuki Aburatani. Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma. Cancer Research 2004; 64(7): 2418 doi: 10.1158/0008-5472.CAN-03-2191
|
| 3 |
Xiao‐Bo Man, Liang Tang, Bao‐Hua Zhang, Shen‐Jing Li, Xiu‐Hua Qiu, Meng‐Chao Wu, Hong‐Yang Wang. Upregulation ofGlypican‐3expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers. Liver International 2005; 25(5): 962 doi: 10.1111/j.1478-3231.2005.01100.x
|
| 4 |
Jorge Filmus, Mariana Capurro. Glypican-3 and Alphafetoprotein as Diagnostic Tests for Hepatocellular Carcinoma. Molecular Diagnosis 2004; 8(4): 207 doi: 10.1007/BF03260065
|
| 5 |
Xiao-Yan Cao, Jie Liu, Zhao-Rui Lian, Marcy Clayton, Jia-Lu Hu, Ming-Hua Zhu, Dai-Ming Fan, Mark Feitelson. Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice. World Journal of Gastroenterology 2001; 7(4): 575-578 doi: 10.3748/wjg.v7.i4.575
|
| 6 |
JuanPing Yu, Qiang Ma, Bin Zhang, RuiJuan Ma, XiGuang Xu, MingSong Li, WeiWen Xu, Ming Li. Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis. Science China Life Sciences 2013; 56(3): 234 doi: 10.1007/s11427-013-4451-y
|
| 7 |
Hamed Azhdari Tehrani, Masood Zangi, Mobina Fathi, Kimia Vakili, Moustapha Hassan, Elham Rismani, Nikoo Hossein-Khannazer, Massoud Vosough. GPC-3 in hepatocellular carcinoma; A novel biomarker and molecular target. Experimental Cell Research 2025; 444(2): 114391 doi: 10.1016/j.yexcr.2024.114391
|
| 8 |
Regina Cheuk-Lam Lo, Irene Oi-Lin Ng. Hepatocellular tumors: Immunohistochemical analyses for classification and prognostication. Chinese Journal of Cancer Research 2011; 23(4): 245 doi: 10.1007/s11670-011-0245-6
|
| 9 |
Dina Kandil, Gladwyn Leiman, Mark Allegretta, Winifred Trotman, Liron Pantanowitz, Robert Goulart, Mark Evans. Glypican-3 immunocytochemistry in liver fine-needle aspirates. Cancer 2007; 111(5): 316 doi: 10.1002/cncr.22954
|
| 10 |
Gang Zhang, Mian Long, Zhe-Zhi Wu, Wei-Qun Yu. Mechanical properties of hepatocellular carcinoma cells. World Journal of Gastroenterology 2002; 8(2): 243-246 doi: 10.3748/wjg.v8.i2.243
|
| 11 |
Juan-Ping Yu, Xi-Guang Xu, Rui-Juan Ma, Shi-Ni Qin, Cong-Rong Wang, Xiao-Bo Wang, Ming Li, Ming-Song Li, Qiang Ma, Wei-Wen Xu. Development of a Clinical Chemiluminescent Immunoassay for Serum GPC3 and Simultaneous Measurements Alone With AFP and CK19 in Diagnosis of Hepatocellular Carcinoma. Journal of Clinical Laboratory Analysis 2015; 29(2): 85 doi: 10.1002/jcla.21733
|
| 12 |
Ahmad Saad, Benjamin Liet, Gilles Joucla, Xavier Santarelli, Justine Charpentier, Stéphane Claverol, Christophe F. Grosset, Véronique Trézéguet. Role of Glycanation and Convertase Maturation of Soluble Glypican-3 in Inhibiting Proliferation of Hepatocellular Carcinoma Cells. Biochemistry 2018; 57(7): 1201 doi: 10.1021/acs.biochem.7b01208
|
| 13 |
Xiao-Yan Cao, Jie Liu, Zhao-Rui Lian, Marcy Clayton, Jia-Lu Hu, Ming-Hua Zhu, Dai-Ming Fan, Mark Feitelson. Cloning of differentially expressed genes in human hepatocellular carcinoma and nontumor liver. World Journal of Gastroenterology 2001; 7(4): 579-582 doi: 10.3748/wjg.v7.i4.579
|
| 14 |
Dina Kandil, Gladwyn Leiman, Mark Allegretta, Mark Evans. Glypican‐3 protein expression in primary and metastatic melanoma. Cancer Cytopathology 2009; 117(4): 271 doi: 10.1002/cncy.20032
|
| 15 |
Samah S. Elbasateeny, Taiseer R. Ibrahim. The utility of immunohistochemical expression of glypican-3 (GPC3) and enhancer of zeste homologue-2 (EZH2) protein in the diagnosis of liver nodules. Egyptian Journal of Pathology 2016; 36(2): 267 doi: 10.1097/01.XEJ.0000508565.38041.da
|
| 16 |
Jing Fu, Hongyang Wang. Precision diagnosis and treatment of liver cancer in China. Cancer Letters 2018; 412: 283 doi: 10.1016/j.canlet.2017.10.008
|
| 17 |
|
| 18 |
Jorge Filmus, Mariana Capurro. Glypican-3 and Alphafetoprotein as Diagnostic Tests for Hepatocellular Carcinoma. Molecular Diagnosis 2004; 8(4): 207 doi: 10.1007/BF03260065
|